Filing Details
- Accession Number:
- 0001628280-25-034818
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-11 17:49:49
- Reporting Period:
- 2025-06-02
- Filing Date:
- 2025-07-11
- Accepted Time:
- 2025-07-11 17:49:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 1600 West End Ave. Suite 1300 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Transaction Summary
| Purchased: | 168 shares | Avg. Price: $4.80 | Total Value: $807.20 |
| Number of Shares After Transactions: | 5,699,428 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-02 | 8 | $5.20 | 5,699,268 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-03 | 8 | $5.61 | 5,699,276 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-04 | 8 | $5.75 | 5,699,284 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-05 | 8 | $5.46 | 5,699,292 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-06 | 8 | $5.57 | 5,699,300 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-09 | 8 | $5.94 | 5,699,308 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-10 | 8 | $6.00 | 5,699,316 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-11 | 8 | $5.57 | 5,699,324 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-12 | 8 | $5.67 | 5,699,332 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-13 | 8 | $5.81 | 5,699,340 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-16 | 8 | $5.32 | 5,699,348 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-17 | 8 | $5.61 | 5,699,356 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-18 | 8 | $5.52 | 5,699,364 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-20 | 8 | $5.29 | 5,699,372 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-23 | 8 | $4.61 | 5,699,380 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-24 | 8 | $3.91 | 5,699,388 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-25 | 8 | $3.27 | 5,699,396 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-26 | 8 | $2.71 | 5,699,404 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-27 | 8 | $2.60 | 5,699,412 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-30 | 16 | $2.74 | 5,699,428 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
Billionaire Hedge Funds
